Literature DB >> 32223648

Association between mean corpuscular volume and severity of coronary artery disease in the Northern Chinese population: a cross-sectional study.

Huaiyu Wang1, Guang Yang2, Juan Zhao1, Mengchang Wang1.   

Abstract

Entities:  

Keywords:  Gensini score; Mean corpuscular volume; coronary angiography; coronary artery disease; cross-sectional study; red blood cell distribution width

Mesh:

Year:  2020        PMID: 32223648      PMCID: PMC7133409          DOI: 10.1177/0300060519896713

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


× No keyword cloud information.

Introduction

Coronary artery disease (CAD) is the most common form of heart disease and affects millions of people worldwide.[1] Stenosis of the coronary artery, which may lead to myocardial infarction or sudden cardiac death, reduces blood flow and oxygen to the heart muscle.[2] Many risk factors, including smoking, diabetes, hypertension, and obesity, are associated with CAD.[3-6] Red blood cells (RBCs) deliver oxygen to the whole body via the circulatory system.[7] The mean corpuscular volume (MCV), a measure of the size of RBCs, is closely associated with endothelial dysfunction and cardiovascular events.[8] Additionally, the RBC distribution width (RDW), an important biomarker in patients with pathological conditions, is closely associated with the incidence of CAD.[9,10] However, little is known about the role of routine blood examinations such as measurement of the MCV, RDW, and RBC count in the progression of coronary artery stenosis. We therefore performed a cross-sectional study to explore whether the MCV, RDW, and RBC count are correlated with the severity of CAD in the Northern Chinese population.

Methods

Study population

From July 2015 to February 2017, 1326 in-hospital patients were recruited from the database of Shaanxi Provincial People’s Hospital and the First Affiliated Hospital of Xi’an Jiaotong University. All patients had standard clinical indications for cardiac interventional therapy and underwent coronary angiography (CAG) during the hospital stay.[11] The exclusion criteria were (1) missing data from CAG reports and medical records, (2) the presence of haematological disease (including RBC disorders, white blood cell disorders, and platelet disorders) and systemic disease, and (3) pregnancy. All patients provided written informed consent, and their data were anonymised and de-identified before the statistical analysis. The study protocol was approved by the Ethics Committee of Shaanxi Provincial People’s Hospital and the First Affiliated Hospital of Xi’an Jiaotong University. Hypertension was diagnosed as an in-office blood pressure measurement of >140/90 mmHg or 24-hour ambulatory blood pressure measurement of >135/85 mmHg.[12] Diabetes mellitus was defined as a fasting plasma glucose level of ≥7.0 mmol/L (126 mg/dL) or 2-hour post-load plasma glucose level of ≥11.0 mmol/L (200 mg/dL).[13] Smoking was defined as currently smoking every day or some days or ever having smoked 100 cigarettes.[14] Dyslipidaemia was defined as a triglyceride level of ≥150 mg/dL, low-density lipoprotein level of ≥130 mg/dL, high-density lipoprotein level of ≤40 mg/dL, or total cholesterol level of ≥200 mg/dL.[15]

Biochemical measurements

Routine haematology tests included measurement of the white blood cell count, RBC count, MCV, RDW, haemoglobin level, and haematocrit using ethylenediamine tetraacetic acid tubes. Blood samples were collected from all patients in the morning after a 12-hour fasting period. The MCV, RDW, RBC count, haematocrit, and haemoglobin level were detected by automated haematology analysers. The following formulas were used: MCV = haematocrit/RBC count and RDW = (coefficient of variability of RBCs/mean MCV) × 100. The MCV was divided into the first tertile (<91.2 fl, n = 442), second tertile (91.2–95.2 fl, n = 442), and third tertile (>95.3 fl, n = 442).

CAG results

All patients underwent CAG using a standard clinical technique through the femoral artery or radial artery approach.[11] The CAG findings were reported and checked by two interventional cardiologists. The severity of CAD was calculated by the Gensini score. In the Gensini scoring system, a score of 0 indicates no abnormality, 1 represents stenosis of ≤25%, 2 represents stenosis of 26% to 50%, 4 represents stenosis of 51% to 75%, 16 represents stenosis of 76% to 99%, and 32 represents complete occlusion. The score is then multiplied by different factors according to the functional significance of the coronary artery stenosis. The importance of the segment is scored from 5.0 for the left main trunk to 0.5 for the most distal segments.[16-18] In the present study, the Gensini scores were categorised into the first quartile (≤5 points, n = 340), second quartile (6–20 points, n = 337), third quartile (21–48 points, n = 319), and fourth quartile (≥49 points, n = 330).

Statistical analysis

Descriptive statistics are presented as percentages for categorical variables and as mean ± standard deviation for continuous variables. The comparisons of continuous variables and categorical variables were based on analysis of variance, Student’s t-test, and the chi-square test. Linear regression analysis was conducted to investigate the relationship between the severity of CAD and several variables (age, sex, smoking, diabetes mellitus, hypertension, heart rate, family history of CAD, hyperlipidaemia, systolic blood pressure, diastolic blood pressure, total cholesterol, high-density lipoprotein, low-density lipoprotein, very-low-density lipoprotein, and MCV). Variables with a P value of <0.05 in the univariate models were then included in the multivariate analyses. A P-value of <0.05 was considered statistically significant. All statistical analyses were performed by SPSS version 24.0 (IBM Corp., Armonk, NY, USA).

Results

Patient characteristics

The descriptive characteristics according to the Gensini score quartiles are shown in Table 1. This study included 1326 patients (927 men, 399 women; mean age, 58.5 ± 10.3 years). Patients in the fourth quartile of the Gensini score were older and comprised a higher proportion of men. The MCV was significantly higher in the fourth quartile of the Gensini score than in the third, second, and first quartiles (94.1 ± 6.7 vs. 93.2 ± 6.4 vs. 92.8 ± 5.1 vs. 92.6 ± 6.2, respectively; P = 0.010). The RDW was also higher in patients in the fourth quartile of the Gensini score than in the third, second, and first quartiles (45.6 ± 5.0 vs. 45.1 ± 4.9 vs. 44.7 ± 3.5 vs. 44.5 ± 3.8, respectively; P = 0.007).
Table 1.

Descriptive characteristics by Gensini score quartiles.

Gensini score quartiles
CharacteristicsTotal(n = 1326)First quartile(n = 340)Second quartile (n = 337)Third quartile (n = 319)Fourth quartile (n = 330)P value
Age, years58.5 ± 10.355.7 ± 9.559.0 ± 9.959.6 ± 10.460.0 ± 10.8<0.001
Sex<0.001
 Male927 (69.9)187 (55.0)237 (70.3)231 (72.4)272 (82.4)
 Female399 (30.1)153 (45.0)100 (29.7)88 (27.6)58 (17.6)
Current smoking590 (44.5)117 (34.4)159 (47.2)156 (48.9)158 (47.9)<0.001
Diabetes mellitus211 (15.9)14 (4.1)46 (13.6)77 (24.1)74 (22.4)<0.001
Hypertension681 (51.4)155 (45.6)171 (50.7)189 (59.2)166 (50.3)0.005
Hyperlipidaemia154 (11.6)31 (9.1)48 (14.2)39 (12.2)36 (10.9)0.203
Family history of CAD394 (29.7)105 (30.9)92 (27.3)110 (34.5)87 (26.4)0.093
Baseline SBP, mmHg134.8 ± 20.5134.2 ± 18.8135.7 ± 18.4135.1 ± 21.9134.3 ± 22.80.763
Baseline DBP, mmHg78.1 ± 11.877.5 ± 11.078.8 ± 11.977.9 ± 11.978.3 ± 12.40.482
Heart rate, bpm75.5 ± 13.774.5 ± 15.274.9 ± 12.575.6 ± 13.175.5 ± 13.70.102
RBCs, 1012/L4.8 ± 4.34.9 ± 3.04.6 ± 3.24.9 ± 3.65.0 ± 6.30.688
Hb, g/L134.4 ± 15.9132.6 ± 15.4134.5 ± 16.5135.3 ± 15.9135.3 ± 15.90.101
RDW, fl45.0 ± 4.444.5 ± 3.844.7 ± 3.545.1 ± 4.945.6 ± 5.00.007
MCV, fl93.2 ± 6.292.6 ± 6.292.8 ± 5.193.2 ± 6.494.1 ± 6.70.010
HCT, %40.2 ± 4.439.8 ± 4.240.3 ± 4.540.5 ± 4.440.4 ± 4.40.142
TC, mmol/L1.8 ± 1.21.7 ± 1.11.8 ± 1.01.7 ± 0.91.9 ± 1.70.431
HDL, mmol/L1.1 ± 0.31.2 ± 0.31.1 ± 0.31.1 ± 0.31.1 ± 0.30.003
LDL, mmol/L2.7 ± 0.92.7 ± 0.82.7 ± 0.92.6 ± 0.92.7 ± 1.00.912
VLDL, mmol/L0.6 ± 0.40.6 ± 0.40.6 ± 0.40.5 ± 0.40.6 ± 0.50.691

Results are presented as mean ± standard deviation or n (%). The P values represent the difference among the four quartiles.

First quartile, ≤5 points; second quartile, 6–20 points; third quartile, 21–48 points; fourth quartile, ≥49 points.

CAD, coronary artery disease; DBP, diastolic blood pressure; Hb, haemoglobin; HCT, haematocrit; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MCV, mean corpuscular volume; RBCs, red blood cells; RDW, red blood cell distribution width; SBP, systolic blood pressure; TC, total cholesterol; VLDL, very-low-density lipoprotein.

Descriptive characteristics by Gensini score quartiles. Results are presented as mean ± standard deviation or n (%). The P values represent the difference among the four quartiles. First quartile, ≤5 points; second quartile, 6–20 points; third quartile, 21–48 points; fourth quartile, ≥49 points. CAD, coronary artery disease; DBP, diastolic blood pressure; Hb, haemoglobin; HCT, haematocrit; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MCV, mean corpuscular volume; RBCs, red blood cells; RDW, red blood cell distribution width; SBP, systolic blood pressure; TC, total cholesterol; VLDL, very-low-density lipoprotein.

Association between Gensini score and MCV

The patients were divided into three groups based on the MCV: <91.2 fl (first grade, n = 442), 91.2 to 95.2 fl (second grade, n = 442), and >95.3 fl (third grade, n = 442). Patients with third-grade MCV had higher Gensini scores than those with second- and first-grade MCV (35.6 ± 36.5 vs. 30.5 ± 33.7 vs. 29.6 ± 30.7, respectively; P = 0.019) (Table 2). Additionally, patients with a higher RDW had higher Gensini scores (data not shown).
Table 2.

Baseline characteristics of MCV categories.

CharacteristicsMCV < 91.2 fl(n = 442)MCV 91.2–95.2 fl (n = 442)MCV >95.3 fl(n = 442)P value
Age, years57.0 ± 10.858.9 ± 10.259.7 ± 9.7<0.001
Sex<0.001
 Male286 (64.7)295 (66.7)346 (78.3)
 Female156 (35.3)147 (33.3)96 (21.7)
Current smoking166 (37.6)186 (42.1)238 (53.8)<0.001
Diabetes mellitus95 (21.5)70 (15.8)46 (10.4)<0.001
Hypertension235 (53.2)240 (54.3)206 (46.6)0.047
Hyperlipidaemia67 (15.2)43 (9.7)44 (10.0)0.017
Family history of CAD139 (31.4)139 (31.4)116 (26.2)0.148
Baseline SBP, mmHg135.6 ± 20.4136.5 ± 20.3132.4 ± 20.80.009
Baseline DBP, mmHg78.8 ± 11.678.8 ± 12.276.8 ± 11.40.012
Heart rate, bpm75.9 ± 13.675.9 ± 14.474.6 ± 13.20.243
TC, mmol/L2.0 ± 1.51.7 ± 1.01.6 ± 1.00.004
HDL, mmol/L1.1 ± 0.31.2 ± 0.31.1 ± 0.30.389
LDL, mmol/L2.7 ± 0.92.7 ± 0.92.5 ± 0.80.033
VLDL, mmol/L0.6 ± 0.50.6 ± 0.40.5 ± 0.40.002
Gensini score29.6 ± 30.730.5 ± 33.735.6 ± 36.50.019

Results are presented as mean  ±  standard deviation or n (%). The P values represent the difference among the three groups.CAD, coronary artery disease; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MCV, mean corpuscular volume; SBP, systolic blood pressure; TC, total cholesterol; VLDL, very-low-density lipoprotein.

Baseline characteristics of MCV categories. Results are presented as mean  ±  standard deviation or n (%). The P values represent the difference among the three groups.CAD, coronary artery disease; DBP, diastolic blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MCV, mean corpuscular volume; SBP, systolic blood pressure; TC, total cholesterol; VLDL, very-low-density lipoprotein. The univariate linear regression analysis showed that the MCV was positively correlated with an increasing Gensini score (β = 0.575, 95% confidence interval [CI] = 0.281–0.870, P < 0.001). After adjustment for age, sex, smoking, hypertension, diabetes, and heart rate, the MCV was still positively associated with the Gensini score (β = 0.503, 95% CI = 0.205–0.801, P = 0.001). The multivariate linear regression model also showed that the RDW (β = 0.818, 95% CI = 0.360–1.276, P < 0.001) and RBC count (β = 0.438, 95% CI = 0.025–0.852, P = 0.038) were closely associated with the Gensini score (Table 3). No significant correlation was found among the haemoglobin level, haematocrit, and Gensini score. We further investigated the relationship between the MCV or RDW and the Gensini score in a subgroup analysis. The results showed that the association of the MCV or RDW with the Gensini score was more prominent in patients with a smoking habit (Supplemental Table 1).
Table 3.

Univariate and multiple linear regression analyses of the Gensini score.

Univariate models
Multivariate adjusted
Variableβ (95% CI)Pβ (95% CI)P
MCV0.575 (0.281–0.870)<0.0010.503 (0.205–0.801)0.001
RDW0.889 (0.429–1.349)<0.0010.818 (0.360–1.276)<0.001
RBC count0.382 (−0.046–0.810)0.0800.438 (0.025–0.852)0.038
Hb0.076 (−0.038–0.190)0.191−0.040 (−0.169–0.088)0.540
HCT0.247 (−0.170–0.663)0.245−0.158 (−0.616–0.301)0.500

Univariate models were adjusted for age, sex, smoking, hypertension, diabetes mellitus, heart rate, hyperlipidaemia, family history of coronary artery disease, systolic blood pressure, diastolic blood pressure, total cholesterol, high-density lipoprotein, low-density lipoprotein, and very-low-density lipoprotein.

Variables with a P value of <0.05 in the univariate models were then included in the multivariate analyses (adjusted for age, sex, smoking, hypertension, diabetes mellitus, and heart rate).

CI, confidence interval; Hb, haemoglobin; HCT, haematocrit; MCV, mean corpuscular volume; RBC, red blood cell; RDW, red blood cell distribution width.

Univariate and multiple linear regression analyses of the Gensini score. Univariate models were adjusted for age, sex, smoking, hypertension, diabetes mellitus, heart rate, hyperlipidaemia, family history of coronary artery disease, systolic blood pressure, diastolic blood pressure, total cholesterol, high-density lipoprotein, low-density lipoprotein, and very-low-density lipoprotein. Variables with a P value of <0.05 in the univariate models were then included in the multivariate analyses (adjusted for age, sex, smoking, hypertension, diabetes mellitus, and heart rate). CI, confidence interval; Hb, haemoglobin; HCT, haematocrit; MCV, mean corpuscular volume; RBC, red blood cell; RDW, red blood cell distribution width.

Discussion

The coronary artery, a blood vessel located in the heart, is a main part of the circulatory system and provides the heart with oxygen and nutrients. Coronary artery stenosis occurs secondary to atherosclerosis in the epicardial coronary arteries. Measurement of the Gensini score is a quick and easy way to evaluate the severity of CAD in clinical practice.[19] This scoring system involves the summation of each lesion score and has been found to be a predictor of the cardiovascular outcome.[19] We therefore used the Gensini score to further explore the relationship between the MCV and the severity of CAD in the present cross-sectional study and found that the MCV was positively correlated with the Gensini score. RBCs, which are produced in the bone marrow, are the most common cell type in the blood.[20] The most important function of RBCs is to deliver oxygen to organs and tissues. The MCV is the mean volume of an RBC, while the RDW is proportionate to the standard deviation of the MCV. The MCV and RDW have been found to be associated with CAD, heart failure, diabetes, stroke, and venous thromboembolism.[21,22] However, the association between the MCV or RDW and the severity of CAD has long remained unknown. In the present study, we investigated the role of the MCV and RDW in the severity of CAD. A previous study showed that the RDW was correlated with the Gensini score.[23] The RDW was also found to be an independent predictor of CAD and the severity of coronary stenosis.[24] In the present study, we found that patients in the Northern Chinese population with a higher MCV and RDW had higher Gensini scores. Moreover, a linear regression analysis was further performed to test the association between the severity of CAD and the MCV. After adjustment for age, sex, smoking, hypertension, diabetes, and heart rate, the MCV and RDW were significantly associated with the severity of CAD. Several reports have discussed mechanisms that might explain the association between the MCV or RDW and the severity of CVD. The RDW is closely associated with coronary atherosclerosis and is a marker of inflammatory processes.[23] In addition, chronic inflammation is one of the main driving forces of atherosclerotic plaque progression.[25] Chronic inflammation can also lead to an increase in the MCV and RDW. Furthermore, Solak et al.[8] showed that the MCV was inversely correlated with flow-mediated dilatation, indicating that the MCV is associated with endothelial function. Therefore, an elevated MCV and RDW may reflect the severity of atherosclerosis. The specific mechanisms underlying these associations require further exploration. The current study has several limitations. First, the patients were recruited from the Northwest region of China; therefore, the results may not be extended to all ethnicities. Second, the study was retrospective, making it difficult to conclude that a causal relationship exists between the MCV or RDW and the severity of CAD. A multi-centre study with a long observation period is needed to verify our findings.

Conclusion

The present study showed that an elevated MCV, RDW, and RBC count were significantly associated with more severe coronary artery stenosis. The MCV, RDW, and RBC count were thus associated with the severity of CAD. Click here for additional data file. Supplemental material, IMR896713 Supplemental Table1 for Association between mean corpuscular volume and severity of coronary artery disease in the Northern Chinese population: a cross-sectional study by Huaiyu Wang, Guang Yang, Juan Zhao and Mengchang Wang in Journal of International Medical Research
  24 in total

1.  Association of coronary atherosclerotic burden with clinical presentation and prognosis in patients with stable and unstable coronary artery disease.

Authors:  Gjin Ndrepepa; Tomohisa Tada; Massimiliano Fusaro; Salvatore Cassese; Lamin King; Martin Hadamitzky; Hans-Ullrich Haase; Albert Schömig; Adnan Kastrati; Jürgen Pache
Journal:  Clin Res Cardiol       Date:  2012-07-08       Impact factor: 5.460

Review 2.  Treatment of Hypertension in Patients with Coronary Artery Disease. A Case-Based Summary of the 2015 AHA/ACC/ASH Scientific Statement.

Authors:  Clive Rosendorff
Journal:  Am J Med       Date:  2015-12-02       Impact factor: 4.965

Review 3.  In the clinic. Type 2 diabetes.

Authors:  Sandeep Vijan
Journal:  Ann Intern Med       Date:  2010-03-02       Impact factor: 25.391

4.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redón; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844

Review 5.  Aortic stenosis and coronary artery disease: what do we know? What don't we know? A comprehensive review of the literature with proposed treatment algorithms.

Authors:  Jean-Michel Paradis; Justin Fried; Tamim Nazif; Ajay Kirtane; Kishore Harjai; Omar Khalique; Kendra Grubb; Isaac George; Rebecca Hahn; Mathew Williams; Martin B Leon; Susheel Kodali
Journal:  Eur Heart J       Date:  2014-06-26       Impact factor: 29.983

6.  Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application.

Authors:  Christoph Sinning; Lars Lillpopp; Sebastian Appelbaum; Francisco Ojeda; Tanja Zeller; Renate Schnabel; Edith Lubos; Annika Jagodzinski; Till Keller; Thomas Munzel; Christoph Bickel; Stefan Blankenberg
Journal:  Clin Res Cardiol       Date:  2013-03-23       Impact factor: 5.460

Review 7.  Prognostic value of red blood cell distribution width for patients with heart failure: a systematic review and meta-analysis of cohort studies.

Authors:  Yuan-Lan Huang; Zhi-De Hu; Shi-Jian Liu; Yi Sun; Qin Qin; Bao-Dong Qin; Wei-Wei Zhang; Jian-Rong Zhang; Ren-Qian Zhong; An-Mei Deng
Journal:  PLoS One       Date:  2014-08-18       Impact factor: 3.240

8.  "Correlation of red blood cell distribution width with the severity of coronary artery disease-A single center study".

Authors:  Praveen Nagula; Suneetha Karumuri; Adikesava Naidu Otikunta; Subba Reddy Venkata Yerrabandi
Journal:  Indian Heart J       Date:  2017-04-24

9.  Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus.

Authors:  Andrew Xanthopoulos; Gregory Giamouzis; Andreas Melidonis; Takeshi Kitai; Efi Paraskevopoulou; Pinelopi Paraskevopoulou; Sotirios Patsilinakos; Filippos Triposkiadis; John Skoularigis
Journal:  Cardiovasc Diabetol       Date:  2017-07-06       Impact factor: 9.951

10.  Cigarette Smoking Is Associated with a Lower Prevalence of Newly Diagnosed Diabetes Screened by OGTT than Non-Smoking in Chinese Men with Normal Weight.

Authors:  Xuhong Hou; Jieyuzhen Qiu; Peizhu Chen; Jun Lu; Xiaojing Ma; Juming Lu; Jianping Weng; Linong Ji; Zhongyan Shan; Jie Liu; Haoming Tian; Qiuhe Ji; Dalong Zhu; Jiapu Ge; Lixiang Lin; Li Chen; Xiaohui Guo; Zhigang Zhao; Qiang Li; Zhiguang Zhou; Wenying Yang; Weiping Jia
Journal:  PLoS One       Date:  2016-03-08       Impact factor: 3.240

View more
  3 in total

1.  Associations of Red Cell Distribution Width With Coronary Artery Calcium in the General Population.

Authors:  Jingxue Pan; Yan Borné; Isabel Gonçalves; Margaretha Persson; Gunnar Engström
Journal:  Angiology       Date:  2021-11-24       Impact factor: 3.619

2.  Serum miR-497-5p serves as a diagnostic biomarker for acute coronary syndrome and predicts the occurrence of major adverse cardiovascular events after percutaneous coronary intervention.

Authors:  Tao Chen; Xueshan Zhang; Wei Qian; Ran Zhou; Mingyu Su; Yanfeng Ma
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

3.  A Mendelian randomization-based exploration of red blood cell distribution width and mean corpuscular volume with risk of hemorrhagic strokes.

Authors:  Jundong Liu; Elizabeth L Chou; Kui Kai Lau; Peter Yat Ming Woo; Tsz Kin Wan; Ruixuan Huang; Kei Hang Katie Chan
Journal:  HGG Adv       Date:  2022-08-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.